The Wall Street Journal – by Erin Mendell
A Chinese drug regulator gave provisional approval to a Covid-19 vaccine developed by a state-owned company, providing a green light for mass inoculation roughly a year after the pandemic first emerged in central China.
Read the whole story on wsj.com